• News item QPS Mass Balance

Xendo announces Partnership with QPS for the conduct of early phase radiolabelled studies in man

Groningen, the Netherlands, April 06, 2010: Xendo Drug Development BV, a European contract research organization (CRO), announced its latest collaboration with QPS LLC. As part of this collaboration, Xendo will partner with QPS to conduct and support early phase human radiolabelled studies. Please click on pdf file to read the details.